Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ

  • FDA Approval
  • May 29, 2023, 11:46 UTC
  • 30
  • 0 comments

FDA approve IMIPRAMINE HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • May 29, 2023, 11:46 UTC
  • 32
  • 0 comments

FDA approve IMIPRAMINE HYDROCHLORIDE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • May 29, 2023, 11:46 UTC
  • 30
  • 0 comments

FDA approve RISEDRONATE SODIUM

Comment Full text

HOSPIRA

  • FDA Approval
  • May 29, 2023, 11:46 UTC
  • 33
  • 0 comments

FDA approve ROPIVACAINE HYDROCHLORIDE

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • May 29, 2023, 11:46 UTC
  • 33
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

BLUE EARTH DIAGNOSTICS LTD.

  • FDA Approval
  • May 26, 2023, 16:53 UTC
  • 35
  • 0 comments

FDA approve FLOTUFOLASTAT F-18

Comment Full text

HERON THERAPS INC

  • FDA Approval
  • May 26, 2023, 16:10 UTC
  • 30
  • 0 comments

FDA approve GRANISETRON

Comment Full text

BAYER HLTHCARE

  • FDA Approval
  • May 26, 2023, 16:07 UTC
  • 32
  • 0 comments

FDA approve IOPROMIDE

Comment Full text

BAYER HEALTHCARE LLC

  • FDA Approval
  • May 26, 2023, 16:07 UTC
  • 31
  • 0 comments

FDA approve LORATADINE

Comment Full text

BAYER HLTHCARE

  • FDA Approval
  • May 26, 2023, 16:03 UTC
  • 32
  • 0 comments

FDA approve IOPROMIDE

Comment Full text
  • Previous
  • 801
  • 802
  • 803
  • 804
  • 805
  • Next

Search

News categories

  • Technical Exchange News(12112)
  • Event(5488)
  • SEC News(253034)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(151220)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin